As a tumor-specific promoter, a polynucleotide is used which comprises the nucleotide sequence depicted in SEQ ID NO:1 or a nucleotide sequence capable of hybridizing to a nucleotide sequence complementary to the nucleotide sequence depicted in SEQ ID NO:1 under stringent conditions and which has a tumor-specific promoter activity.